Bionano Genomics (BNGO) Research & Development (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Research & Development data on file, last reported at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 32.45% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.1 million (down 30.18% YoY), and the FY2025 full-year result was $11.4 million, down 54.14% from the prior year.
• Research & Development fell to $3.1 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $14.6 million in Q2 2023 to a low of $2.4 million in Q1 2025.
• A 5-year average of $8.4 million and a median of $9.8 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 293.09% in 2022 and sank 75.76% in 2025, its largest moves.
• Tracing BNGO's Research & Development over 5 years: stood at $14.0 million in 2022, then decreased by 16.49% to $11.7 million in 2023, then tumbled by 70.31% to $3.5 million in 2024, then decreased by 7.05% to $3.2 million in 2025, then slipped by 2.79% to $3.1 million in 2026.
• Business Quant data shows BNGO's Research & Development at $3.1 million in Q1 2026, $3.2 million in Q4 2025, and $2.8 million in Q3 2025.